Discriminative stimulus effects of 8-hydroxy-2-(di-n- propylamino)tetralin in pigeons and rats: Species similarities and differences

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 1, 1998, Pages 238-249

  Kleven, Mark S ^a   Koek, Wouter ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ELTOPRAZINE; IDAZOXAN; LISURIDE; PENBUTOLOL; SEROTONIN 1A ANTAGONIST; YOHIMBINE;

ANIMAL EXPERIMENT; ANXIETY NEUROSIS; ARTICLE; BINDING AFFINITY; LIGAND BINDING; MALE; NONHUMAN; PIGEON; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RAT; REINFORCEMENT; SPECIES DIFFERENCE; STIMULUS RESPONSE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; COLUMBIDAE; DISCRIMINATION LEARNING; MALE; PIPERAZINES; PYRIDINES; PYRIMIDINES; RATS; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SPECIES SPECIFICITY;

EID: 0031934530     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Ahlenius S, Hillegaart V and Wijkström A (1991) Behavioral and biochemical effects of the 5-HT1A receptor agonists flesinoxan and 8-OH-DPAT in the rat. Eur J Pharmacol 200:259-266.
2. Albinsson A, Björk A, Svartengren J, Klint T and Andersson G (1994) Preclinical pharmacology of FG5893: A potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors. Eur J Pharmacol 261:285-294.
3. Arnt J (1989) Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats. Pharmacol Toxicol 64:165-172.
4. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58.
5. Assié M-B, Cosi C and Koek W (1997) 5-HT1A receptor agonist properties of the antipsychotic, nemomapride: Comparison with bormerguride and clozapine. Eur J Pharmacol 334:141-147.
6. Assié M-B and Koek W (1996) Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties. Eur J Pharmacol 304:15-21.
7. Barrett JE and Gleeson S (1992) Discriminative stimulus effects of 8-OH-DPAT in pigeons: antagonism studies with the putative 5-HT1A receptor antagonists BM 7378 and NAN-190. Eur J Pharmacol 217:163-171.
8. Barrett JE and Vanover KE (1993) 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmaoology 112:1-12.
9. Barrett JE and Zhang L (1991) Anticonflict and discriminative stimulus effects of the 5-HT1A compounds WY-47,846 and WY-48,723 and the mixed 5-HT1A agonist/5-HT2 antagonist WY-50,324 in pigeons. Drug Deu Res 24:179-188.
10. Barrett JE, Zhang L, Gleeson S and Gamble EH (1994) Anxiolytic and antidepressant mechanisms of 5-HT1A drugs in the pigeon: Contributions from behavioral studies. Neumsci Biobehav Rev 18:73-83.
11. Bristow LJ, Baucutt L, Thorn L, Hutson PH, Noble A, Beer M, Middlemiss DN and Tricklebank MD (1991) Behavioural and biochemical evidence of the interaction of the putative antipsychotic agent, BMY 12802 with the 5-HT1A receptor. Eur J Pharmacol 204: 21-28.
12. Brocco MJ, Koek W, Degryse A-D and Colpaert FC (1990) Comparative studies on the anti-punishment effects of chlordiazepoxide, buspirone and ritanserin in the pigeon, Geller-Seifter and Vogel conflict procedures. Behav Pharmacol 1:403-418.
13. Colpaert FC (1988) Intrinsic activity and discriminative effects of drugs, in Transduction Mechanisms of Drug Stimuli (Colpaert FC and Balster RL eds) pp 154-160, Springer-Verlag, Berlin.
14. Colpaert FC and Janssen PAJ (1982) Factors regulating drug cue sensitivity: limits of discriminability and the role of a progressively decreasing training dose in cocaine-saline discrimination. Neuropharmacology 21:1187-1194.
15. Colpaert FC, Koek W, Lehmann J, Rivet JM, Lejeune F, Canton H, Bervoets K, Millan MJ, Laubie M and Lavielle G (1992) S 14506: A novel, potent, high-efficacy 5-HT1A agonist and potential anxiolytic agent. Drug Dev Res 26:21-48.
16. Colpaert FC, Niemegeers CJE and Janssen PAJ (1980) Factors regulating drug cue sensitivity: Limits of discriminability and the role of a progressively decreasin training dose in fentanyl-saline discrimination. J Pharmacol Exp Ther 212:474-480.
17. Cunningham KA, Callahan PM and Appel JB (1987) Discriminative stimulus properties of 8-hydroxy-2-(di-N-propylamino)-tetralin (8-OHDPAT): Implications for understanding the actions of novel anxiolytics. Eur J Pharmacol 138:29-36.
18. De Vry J (1996) 5-HT1A receptors in psychopathology and the mechanism of action of clinically effective therapeutic agents. Drug News Perspect 9:270-280.
19. Deakin JFW (1993) A review of clinical efficacy of 5-HT1A agonists in anxiety an depression. J Psychopharmacol 7:283-289.
20. Foreman MM, Fuller RW, Leander JD, Benvenga MJ, Wong DT, Nelson DL, Calligaro DO, Swanson SP, Lucot JB and Flaugh ME (1993) Preclinical studies on LY228729: A potent and selective serotonin1A agonist. J Pharmacol Exp Ther 267:58-71.
21. Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y and Fletcher A (1996) A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur J Pharmacol 281:81-88.
22. Fuller RW and Snoddy HD (1987) Influence of route of administration on potency of the selective 5-HT!A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats. Life Sci 58:409-412.
23. Gardner CR (1989) The discriminative stimulus properties of the 5HT1 agonist RU 24969. Pharmacol Biochem Behav 33:761-764.
24. Glennon RA, Naiman NA, Pierson ME and Titeler M (1988) NAN-190: An arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Eur J Pharmacol 154:339-341.
25. Greuel JM and Glaser T (1992) The putative 5-HT1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro. Eur J Pharmacol 211:211-219.
26. Hjorth S, Bengtsson HJ and Milano S (1996) Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo. Eur J Pharmacol 316:43-47.
27. Hjorth S and Carlsson A (1986) Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? Eur J Pharmacol 129:131-138.
28. Hjorth S and Sharp T (1993) In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. J Pharmacol Exp Ther 265:707-712.
29. Howard JL and Pollard GT (1990) Effects of buspirone in the Geller-Seifter conflict test with incremental shock. Drug Dev Res 19:37-49.
30. Hoyer E, Clarke DE, Fozard JR, Hartic PR, Martin GR, Mylecharane EJ, Saxena PR and Humphrey PPA (1994) VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203.
31. Hubert JJ (1984) Bioassay. pp 61-62, Kendall/Hunt, Dubuque, Iowa.
32. Humphrey PPA, Hartig P and Hoyer D (1993) A proposed nomenclature for 5-HT receptors. Trends Pharmacol Sct 14:233-236.
33. Jolas T, Haj DS, Lanfumey L, Fattaccini CM, Kidd EJ, Adrien J, Gozlan H, Guardiola LB and Hamon M (1993) (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 347:453-463.
34. Kleven MS, Assié MB and Koek W (1997) Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. II Drug discrimination and behavioral observation studies in rats. J Pharmacol Exp Ther 282:747-759.
35. HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon. J Pharmacol Exp Ther 276:388-397.
36. Koek W, Kleven MS and Colpaert FC (1995) Effects of the NMDA antagonist, dizocilpine, in various drug discriminations: Characterization of intermediate levels of drug lever selection. Behav Pharmacol 6:590-600.
37. Koek W and Woods JH (1988) Partial generalisation in pigeons trained to discriminate morphine from saline: Applications of receptor theory. Psychopharmacology 96:S32.
38. Krisch I and Bole VB (1994) Behavioral studies on LEK-8804, a new ergoline derivative with potent 5-HT1A receptor agonist and 5-HT2 receptor antagonist activity. Pharmacol Biochem Behav 47:301-305.
39. Litchfield JT Jr. and Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113.
40. Löscher W and Hönack D (1993) Effects of the novel 5-HT1A receptor antagonist, (+)-WAY 100135, on stereotyped behaviour induced by the NMDA receptor antagonist dizocilpine in rats. Eur J Pharmacol 242:99-104.
41. Martin GR and Humphrey P (1994) Receptors for 5-hydroxytryptamine: Current perspectives on classification and nomenclature. Neuropharmacology 33:261-273.
42. Mir AK, Hibert M, Tricklebank MD, Middlemiss DN, Kidd EJ and Fozard JR (1988) MDL 72832: A potent and stereoselective ligand at central and peripheral 5-HT1A receptors. Eur J Pharmacol 149:107-120.
43. Morgan D and Picker MJ (1995) Discriminative stimulus effects of the 5HT1A agonist 8-OH-DPAT: attenuation by mu but not by kappa opioids. Psychopharmacology 122:336-345.
44. Mos J, Van Hest A, Van Drimmelen M, Herremans AHJ and Olivier B (1997) The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons. Eur J Pharmacol 325: 145-153.
45. Moser PC, Tricklebank MD, Middlemiss DN, Mir AK, Hibert MF and Fozard JR (1990) Characterisation of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: Comparison with buspirone, 8-OH-DPAT and diazepam. Br J Pharmacol 99:343-349.
46. Nanry KP, Howard JL and Pollard GT (1991) Effects of buspirone and other anxiolytics on punished key-pecking in the pigeon. Drug Dev Res 24:269-276.
47. Newman-Tancredi A, Chaput C, Verrièle L and Millan MJ (1996) Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors. Neuropharmacology 35:119-121.
48. O'Neill MF, Fernández AG and Palacios JM (1996) GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test. Pharmacol Biochem Behav 53:535-539.
49. Overton DA (1974) Experimental methods for the study of state-dependent learning. Fed Proc 33:1800-1813.
50. Overton DA (1982) Comparison of the degree of discriminability of various drugs using the t-maze drug discrimination paradigm. Psychopharmacology 76:385-395.
51. Pauwels PJ and Colpaert FC (1996) Selective antagonism of human 5-HT1D and 5-HT1B receptor-mediated responses in stably transfected C6-glial cells by ketanserin and GR 127,935. Eur J Pharmacol 300:141-145.
52. Rabin RA and Winter JC (1993) Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin. Eur J Pharmacol 235: 237-243.
53. Riblet LA, Taylor DP, Eison MS and Stanton HC (1982) Pharmacology and neurochemistry of buspirone. J Clin Psychiatry 12:11-16.
54. Romero L, Hervás I and Artigas F (1996) The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neurosci Lett 219:123-126.
55. Sanchez C, Arnt J and Moltzen E (1996) Assessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models. Eur J Pharmacol 315:245-254.
56. Sanger DJ and Schoemaker H (1992) Discriminative stimulus properties of 8-OH-DPAT: relationship to affinity for 5HT1A receptors. Psychopharmacology 108:85-92.
57. Saxena PR (1994) Modern 5-HT receptor classification and 5-HT based drugs. Exp Opin Invest Drugs. 3:513-523.
58. Saxena PR (1995) Serotonin receptors: Subtypes, functional responses and therapeutic relevance. Pharmacol Ther 66:339-368.
59. 3H]8-OH-DPAT labels the serotonin transporter in the rat striatum. Eur J Pharmacol 124:371-373.
60. Schreiber R, Brocco M, Lefebvre de Ladonchamps B, Monneyron S and Millan MJ (1995a) A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin. J Pharmacol Exp Ther 275:822-831.
61. Schreiber R, Brocco M, Lefebvre de Ladonchamps B and Millan MJ (1995b) Involvement of 5-HT1A receptors in the anxiolytic action of S 14671 in the pigeon conflict test. Pharmacol Biochem Behau 51:211-215.
62. Tallarida RJ and Murray RB (1987) Manual of Pharmacological Calculations with Computer Programs. Springer Verlag, New York.
63. Tricklebani MD, Neill J, Kidd EJ and Fozard JR (1987) Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-N-propylamino) tetralin (8-OH-DPAT) by the putative 5HT-1a receptor. Eur J Pharmacol 133:47-56.
64. Waeber C, Dietl MM, Hoyer D and Palacios JM (1989a) 5-HT1 receptors in the vertebrate brain. Regional distribution examined by autoradiography. Naunyn-Schmiedeberg's Arch Pharmacol 340:486-494.
65. Waeber C, Schoeffter P, Palacios JM and Hoyer D (1989b) 5-HT1D receptors in guinea-pig and pigeon brain. Radioligand binding and biochemical studies. Naunyn-Schmiedeberg's Arch Pharmacol 340:479-485.
66. Winter JC and Rabin RA (1992) Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. J Pharmacol Exp Ther 263:682-689.
67. Ybema CE, Olivier B, Mos J and Slangen JL (1992) Discriminative stimulus effects of the serenic eltoprazine, Behau Pharmacol 3:suppl 1, 39-40.
68. Ybema CE, Slangen JL, Olivier B and Mos J (1993) Dose-dependent discriminative stimulus properties of 8-OH-DPAT. Behav Pharmacol 4:610-624.
69. Yocca FD (1990) Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postsynaptic 5-HT1A receptors. J Clin Psychopharmacol 10:suppl 3, 6S-12S.
70. Young AM, Masaki MA and Geula C (1992) Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. J Pharmacol Exp Ther 261:246-257.
71. Zhang L and Barrett JE (1991) Modification of the discriminative stimulus effects of 8-OH-DPAT, buspirone and the beta-adrenoreceptor antagonist pindolol after chronic administration of the 5-HT1A agonist 8-OH-DPAT in the pigeon. Behav Pharmacol 2:369-375.